Feedback / Questions
lutetium Lu 177 rofapitide tetraxetan (AAA614) - Novartis
AiRuiKa (camrelizumab) - Elevar Therapeutics
http://www.ncbi.nlm.nih.gov/pubmed/42530282
Hongyu Yang; Lixian Mou; Wenlu Zheng; Yemei Liu; Yue Chen
Jul 31, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next